BNTX
Price
$94.52
Change
-$0.51 (-0.54%)
Updated
Dec 26 closing price
Capitalization
22.73B
73 days until earnings call
Intraday BUY SELL Signals
VERA
Price
$53.58
Change
-$2.09 (-3.75%)
Updated
Dec 26 closing price
Capitalization
3.8B
82 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BNTX vs VERA

Header iconBNTX vs VERA Comparison
Open Charts BNTX vs VERABanner chart's image
BioNTech SE American Depositary Share
Price$94.52
Change-$0.51 (-0.54%)
Volume$503.6K
Capitalization22.73B
Vera Therapeutics
Price$53.58
Change-$2.09 (-3.75%)
Volume$721.12K
Capitalization3.8B
BNTX vs VERA Comparison Chart in %
View a ticker or compare two or three
VS
BNTX vs. VERA commentary
Dec 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BNTX is a StrongBuy and VERA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 27, 2025
Stock price -- (BNTX: $94.52 vs. VERA: $53.58)
Brand notoriety: BNTX and VERA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BNTX: 43% vs. VERA: 43%
Market capitalization -- BNTX: $22.73B vs. VERA: $3.8B
BNTX [@Biotechnology] is valued at $22.73B. VERA’s [@Biotechnology] market capitalization is $3.8B. The market cap for tickers in the [@Biotechnology] industry ranges from $117.45B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BNTX’s FA Score shows that 1 FA rating(s) are green whileVERA’s FA Score has 0 green FA rating(s).

  • BNTX’s FA Score: 1 green, 4 red.
  • VERA’s FA Score: 0 green, 5 red.
According to our system of comparison, VERA is a better buy in the long-term than BNTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BNTX’s TA Score shows that 5 TA indicator(s) are bullish while VERA’s TA Score has 5 bullish TA indicator(s).

  • BNTX’s TA Score: 5 bullish, 5 bearish.
  • VERA’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, VERA is a better buy in the short-term than BNTX.

Price Growth

BNTX (@Biotechnology) experienced а +2.18% price change this week, while VERA (@Biotechnology) price change was +4.61% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.36%. For the same industry, the average monthly price growth was +0.27%, and the average quarterly price growth was +54.56%.

Reported Earning Dates

BNTX is expected to report earnings on Mar 10, 2026.

VERA is expected to report earnings on Mar 19, 2026.

Industries' Descriptions

@Biotechnology (+0.36% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BNTX($22.7B) has a higher market cap than VERA($3.8B). VERA YTD gains are higher at: 26.697 vs. BNTX (-17.051). BNTX has higher annual earnings (EBITDA): 171M vs. VERA (-244.06M). BNTX has more cash in the bank: 14.5B vs. VERA (497M). VERA has less debt than BNTX: VERA (77.2M) vs BNTX (245M). BNTX has higher revenues than VERA: BNTX (3.15B) vs VERA (0).
BNTXVERABNTX / VERA
Capitalization22.7B3.8B597%
EBITDA171M-244.06M-70%
Gain YTD-17.05126.697-64%
P/E Ratio161.76N/A-
Revenue3.15B0-
Total Cash14.5B497M2,918%
Total Debt245M77.2M317%
FUNDAMENTALS RATINGS
BNTX: Fundamental Ratings
BNTX
OUTLOOK RATING
1..100
65
VALUATION
overvalued / fair valued / undervalued
1..100
82
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
91
PRICE GROWTH RATING
1..100
75
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
40

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BNTXVERA
RSI
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
84%
Momentum
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 2 days ago
80%
MACD
ODDS (%)
Bullish Trend 2 days ago
66%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
70%
Bullish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 4 days ago
73%
Bullish Trend 4 days ago
86%
Declines
ODDS (%)
Bearish Trend 10 days ago
81%
Bearish Trend 18 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 5 days ago
71%
Bearish Trend 2 days ago
82%
Aroon
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
BNTX
Daily Signal:
Gain/Loss:
VERA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FAMDX24.320.01
+0.04%
FAM Small Cap Institutional
DSHZX13.16N/A
N/A
Brinker Capital Destinations Shelter Z
ALVCX22.10N/A
N/A
American Beacon Large Cap Value C
QRSAX43.04-0.01
-0.02%
FPA Queens Road Small Cap Value Advisor
JUEAX27.09-0.01
-0.04%
JPMorgan US Equity A

BNTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BNTX has been loosely correlated with MRNA. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if BNTX jumps, then MRNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BNTX
1D Price
Change %
BNTX100%
-0.54%
MRNA - BNTX
54%
Loosely correlated
-4.73%
SMMT - BNTX
53%
Loosely correlated
-1.31%
TIL - BNTX
46%
Loosely correlated
-1.31%
NVAX - BNTX
44%
Loosely correlated
-1.59%
KYMR - BNTX
44%
Loosely correlated
-2.18%
More

VERA and

Correlation & Price change

A.I.dvisor indicates that over the last year, VERA has been loosely correlated with LYRA. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if VERA jumps, then LYRA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VERA
1D Price
Change %
VERA100%
-3.75%
LYRA - VERA
53%
Loosely correlated
+0.28%
KYMR - VERA
52%
Loosely correlated
-2.18%
CRNX - VERA
42%
Loosely correlated
-1.54%
VYGR - VERA
41%
Loosely correlated
+0.25%
BNTX - VERA
41%
Loosely correlated
-0.54%
More